Abstract Submission Guidelines

• The deadline for abstract submission is August 15, 2026
• All abstracts must be submitted in English through the official website
• There is no limit to the number of abstracts an author may submit
• Four presentation formats are available: oral, rapid oral, e-poster, and operative video. Authors may indicate a preferred format; however, the Scientific Committee reserves the right to make the final decision
• All abstracts must include completed results and conclusions at the time of submission. Abstracts based on incomplete, uncollected, or unanalyzed data will not be considered
• All accepted abstracts will be published as submitted in a biomedical journal to be announced in due course
• Abstracts may be withdrawn only during the official withdrawal period from September 25 to September 30, 2026. After this period, withdrawal requests will not be accepted
• Requests for withdrawal during the permitted period must be submitted via email to the Scientific Committee
• Presenting authors must complete registration for PSN 39 by October 5, 2026. Abstracts without a registered presenter by this deadline will be removed from the program
• The Scientific Committee retains full authority to assign the final presentation format (oral or poster), irrespective of the author's stated preference

Abstracts may be edited up to the submission deadline of August 15, 2026. After this date, no revisions or modifications will be permitted.

• Submitting Author: The submitting author is responsible for submitting the abstract and will serve as the primary point of contact for all correspondence. The submitting author must also be the presenting author. Submissions on behalf of others are not permitted
• Requests for changes in authorship or presenter details will not be accommodated
• Abstracts must not contain any form of advertising, trade names, or product-specific promotional content. Generic names and terminology must be used throughout
• All presenters — whether for oral or poster presentations — are required to present in person at the conference venue
• Submitters are responsible for ensuring the accuracy and completeness of all author and presenter contact details at the time of submission
• Poster presenters are required to submit an electronic version of their poster. This version will be displayed both on-site and on the official conference platform

1. Category Select one category that best aligns with your abstract:
   • Case Reports and Case Series
   • Research and Original Articles
   • Systematic Reviews and Meta-analyses
   • Quality Improvement Projects or Clinical Audits
2. Type of Presentation
   • Oral
   • Rapid Oral
   • E-Poster
   • Operative Video
3. Title Use title case with each major word capitalized. Maximum length is 25 words
4. Background Provide the rationale for the study, clearly explaining why it was conducted or documented
5. Objective State the purpose of the study clearly. Specify primary and secondary objectives where applicable
6. Methodology Include study design, setting, duration, sampling method, sample size, inclusion and exclusion criteria, and data analysis techniques. For quantitative studies, describe statistical methods in clear and simple terms. For systematic reviews and meta-analyses, include search strategy and databases used
7. Results Summarize key findings with relevant frequencies and percentages for assessed variables. Use appropriate units and apply correct statistical reporting where necessary
8. Conclusion Provide a clear conclusion that directly addresses the research objective. Do not include recommendations. Avoid repeating results verbatim
9. Keywords Provide at least three relevant keywords
10. Approval or Registration Number For original research: include IRB approval or reference number. For systematic reviews and meta-analyses: include PROSPERO registration number
11. Use of Artificial Intelligence Disclose any use of artificial intelligence and specify how it was applied
12. Conflict of Interest Declare any potential conflicts, including funding, honoraria, affiliations, or personal relationships. If none, state "none to declare"
13. Ethical Approval For original research and clinical studies, include the name of the Institutional Review Board or Ethics Committee along with the approval number
14. Funding Clearly state all sources of funding. If none, please write so
15. Submission Declaration By submitting an abstract, the author confirms all requirements — see the Declaration section below

Eligibility

• Resident trainees in Neurosurgery
• Early-career neurosurgeons (within 7 years of their exit-exam success)

Video Requirements

Recommended Structure

• Title and disclosures
• Clinical presentation
• Preoperative imaging
• Operative strategy
• Intraoperative video footage
• Postoperative imaging and outcomes
• Discussion and key learning points
• References

Additional Submission Materials

• Abstract of up to 250 words, including 3–5 keywords, disclosures, and a statement confirming originality
• A time-stamped transcript that corresponds with the video narration
• Optional figures or tables may be included, provided appropriate copyright permissions are obtained and all materials are original

Review Criteria

• Technical quality and clarity of the video
• Clinical relevance and complexity of the case
• Completeness of outcomes and follow-up information
• Overall quality of video production and narration
• Originality, innovation, and educational value

• Decisions regarding abstract acceptance and presentation category will be communicated via the official conference email between September 21–25, 2026
• All submitting and presenting authors of accepted abstracts are required to prepare their presentations using the official templates provided. No alternative formats will be accepted
• Oral presentations must follow the designated PowerPoint template and poster presentations must use the specified poster template
• All submitting and presenting authors must complete conference registration by October 05, 2026. Abstracts without a registered presenter by this deadline will be withdrawn from the program
• Final presentations (PPTs, posters, or operative videos) must be uploaded to the conference portal by October 15, 2026
• For any technical issues or queries regarding uploads, authors should contact General Enquiries

All accepted abstracts will be automatically considered eligible for the following awards. In-person presentation is mandatory to be eligible. Awards will be presented to the presenting author only.